Lipid-Lowering Therapy and Hemorrhagic Stroke: A Never-Ending Debate of Clinical Implications. Have We Found the Answer?
- PMID: 38323520
- PMCID: PMC11010088
- DOI: 10.1161/JAHA.124.034099
Lipid-Lowering Therapy and Hemorrhagic Stroke: A Never-Ending Debate of Clinical Implications. Have We Found the Answer?
Keywords: Editorials; LDL; cholesterol; hemorrhagic stroke; intracerebral hemorrhage; statins.
Comment on
-
Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Am Heart Assoc. 2024 Feb 20;13(4):e030714. doi: 10.1161/JAHA.123.030714. Epub 2024 Feb 7. J Am Heart Assoc. 2024. PMID: 38323514 Free PMC article.
References
-
- Pezzini A, Grassi M, Iacoviello L, Zedde M, Marcheselli S, Silvestrelli G, DeLodovici ML, Sessa M, Zini A, Paciaroni M, et al. Serum cholesterol levels, HMG‐CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH‐Italy). J Neurol Neurosurg Psychiatry. 2016;87:924–929. doi: 10.1136/jnnp-2015-312736 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
